Article

Multicenter preclinical validation of next-generation CAR T cells: a strategy for harmonization, reproducibility, and its feasibility in clinical translation

2026-04-10

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> Clinical translation of CAR T cell therapies has accelerated, yet preclinical evidence still often originates from single-center studies lacking sufficient robustness. Preclinical confirmatory multicenter studies have been proposed to improve the translational success, but their feasibility in cellular therapies remains unexplored. <h4>Methods</h4> We performed a confirmatory...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9bc05765-5b18-51d6-898c-70ca02c2b226
DOI: 10.64898/2026.04.10.717659

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multicenter preclinical validation of next-generation CAR T cells: a strategy for harmonization, reproducibility, and its feasibility in clinical translationDOI 10.64898/2026.04.10.717659Read

Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignanciesSemantic proximity Read

Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use.Semantic proximity Read

Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic functionSemantic proximity Read

Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivo.Semantic proximity Read

Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop reportSemantic proximity Read

TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challengesSemantic proximity Read

Large Scale In-House Point-of-Care Manufacturing of Clinical Grade Autologous Anti-CD19 CAR T Cells in Saudi ArabiaSemantic proximity Read

Intraperitoneal administration of carcinoembryonic antigen-directed CAR-T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancerSemantic proximity Read

Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapiesSemantic proximity Read

A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasisSemantic proximity Read

Automated GMP-Compatible Production of Universal CAR Tregs for Organ-Targeted Tolerance InductionSemantic proximity Read

Global Manufacturing of CAR T Cell TherapySemantic proximity Read